Impact of a continuing education program on community pharmacists' interventions and asthma medication use: A pilot study

Annals of Pharmacotherapy

Volumn 41, Issue 4, 2007, Pages 574-580

  Rouleau, Rachel ^a,b   Beauchesne, Marie France ^c,d   Laurier, Claudine ^c  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b Institut Nationale de Santé Publique du Québec   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Asthma; Community pharmacy; Continuing education

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ARTICLE; ASTHMA; CONTINUING EDUCATION; DRUG USE; EDUCATION PROGRAM; HUMAN; PHARMACIST; PILOT STUDY; PRIORITY JOURNAL;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; COMMUNITY PHARMACY SERVICES; EDUCATION, PHARMACY, CONTINUING; FEMALE; HUMANS; MALE; PHARMACISTS; PILOT PROJECTS; PROFESSIONAL ROLE; PROGRAM EVALUATION; QUESTIONNAIRES;

EID: 34247180071     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H606     Document Type: Article

References (26)

1. Chapman KR, Ernst P, Greenville A, Dewland P, Zimmerman S. Control of asthma in Canada: failure to achieve guideline targets. Can Respir J 2001;8(suppl A):35A-40A.
2. Fitzgerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR. Asthma control in Canada remains suboptimal: the reality of asthma control (TRAC) study. Can Respir J 2006;13:253-9.
3. Blais R, Grégoire JP, Rouleau R, et al. Ambulatory use of inhaled agonist for the treatment of asthma in Québec: a population-based utilisation review. Chest 2001;199:1316-21.
4. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003;1:CD001117.
5. McLean WM, MacKeigan LD. When does pharmaceutical care impact health outcomes? A comparison of community pharmacy-based studies of pharmaceutical care for patients with asthma. Ann Pharmacother 2005;39:625-31. Epub 1 Mar 2005. DOI 10.1345/aph.1E474.
6. Brown CM, Barner JC, Shepherd MD. Issues and barriers related to the provision of pharmaceutical care in community health centers and migrant health centers. J Am Pharm Assoc 2003;43:75-7.
7. O'Loughlin J, Masson P, Déry V, Fagnan D. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prevent Med 1999;28:324-31.
8. McDonough RP, Rovers JP, Currie JD, Hagel H, Vallandingham J, Sobotka J. Obstacles to the implementation of pharmaceutical care in the community setting. J Am Pharm Assoc 1998;38:87-95.
9. White PT, Pharoah CA, Anderson HR, Freeling P. Randomized controlled trial of small group education on the outcome of chronic asthma in general practice. J R Coll Gen Pract 1989;322:182-6.
10. Clark NM, Gong M, Schork MA, et al. Impact of education for physicians on patient outcomes. Pediatrics 1998;101:831-6.
11. Clark NM, Gong M, Schork MA, et al. Long-term effects of asthma education for physicians on patient satisfaction and use of health services. Eur Respir J 2000;16:15-21.
12. Cowie RL, Underwood MF, Mack S. The impact of asthma management guidelines dissemination on the control of asthma in the community. Can Respir J 2001;8:65-8.
13. Witt K, Knudsen E, Ditlevsen S, Hollnagel H. Academic detailing has no effect on prescribing of asthma medication in Danish general practice: a 3-year randomized controlled trial with 12-monthly follow-ups. Fam Pract 2004;21:248-53.
14. Brown R, Bratton SL, Cabana MD, Kaciroti N, Clark NM. Physician asthma education program improves outcomes for children of low-income families. Chest 2004;126:369-74.
15. Lozano P, Finkelstein JA, Carey VJ, et al. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med 2004;158: 875-83.
16. Broers S, Smets E, Bindels P, Evertsz' FB, Calff M, de Haes H. Training general practitioners in behaviour change counselling to improve asthma medication adherence. Patient Educ Couns 2005;58:279-87.
17. Cabana MD, Slish KK, Evans D, et al. Impact of physician asthma care education on patient outcomes. Pediatrics 2006;117:2149-57.
18. Campbell DT, Stanley JC. Experimental and quasi-experimental designs for research. Boston: Houghton Mifflin Company, 1963.
19. Laurier C. Cartographie provinciale sur l'asthme, www.rqam.ca/docs/ ResumeRapportRechercheDrLaurier2005.pdf (accessed 2006 Sept 26).
20. Lemiere C, Bai T, Blater M, et al. Adult Asthma Consensus Guidelines Update 2003. Can Respir J 2003;11(suppl A):9A-18A.
21. National Asthma Education and Prevention Program Expert Panel Report. Managing asthma during pregnancy: recommendations for pharmacologic treatment - 2004 update. J Allergy Clin Immunol 2005;115:34-46.
22. Schulz M, Verheyen F, Muhlig S, et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol 2001; 41:668-76.
23. McLean W, Gillis J, Waller R. The BC Community pharmacy asthma study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J 2003;195-202.
24. Weinberger M, Murray MD, Marrero EXJ, et al. Effectiveness of pharmacist care for patients with reactive airways disease. JAMA 2002;288: 1594-602.
25. Amsler MR, Murray MD, Tierney WM, et al. Pharmaceutical care in chain pharmacies: beliefs and attitudes of pharmacists and patients. J Am Pharm Assoc 2001;41:850-5.
26. 1 inhalés et des antagonistes des récepteurs des leucotriènes employés dans le traitement de l'asthme. www.cdm.gouv.qc.ca (accessed 2006 Sept 26).